nodes	percent_of_prediction	percent_of_DWPC	metapath
Terazosin—Musculoskeletal discomfort—Vandetanib—thyroid cancer	0.00563	0.00563	CcSEcCtD
Terazosin—Amblyopia—Epirubicin—thyroid cancer	0.00559	0.00559	CcSEcCtD
Terazosin—Insomnia—Vandetanib—thyroid cancer	0.00559	0.00559	CcSEcCtD
Terazosin—Paraesthesia—Vandetanib—thyroid cancer	0.00555	0.00555	CcSEcCtD
Terazosin—Dyspnoea—Vandetanib—thyroid cancer	0.00551	0.00551	CcSEcCtD
Terazosin—Tinnitus—Sorafenib—thyroid cancer	0.00547	0.00547	CcSEcCtD
Terazosin—Dyspepsia—Vandetanib—thyroid cancer	0.00544	0.00544	CcSEcCtD
Terazosin—Decreased appetite—Vandetanib—thyroid cancer	0.00537	0.00537	CcSEcCtD
Terazosin—Fatigue—Vandetanib—thyroid cancer	0.00533	0.00533	CcSEcCtD
Terazosin—Pain—Vandetanib—thyroid cancer	0.00529	0.00529	CcSEcCtD
Terazosin—Constipation—Vandetanib—thyroid cancer	0.00529	0.00529	CcSEcCtD
Terazosin—Arrhythmia—Sorafenib—thyroid cancer	0.00524	0.00524	CcSEcCtD
Terazosin—Amblyopia—Doxorubicin—thyroid cancer	0.00518	0.00518	CcSEcCtD
Terazosin—Malnutrition—Sorafenib—thyroid cancer	0.00511	0.00511	CcSEcCtD
Terazosin—Gastrointestinal pain—Vandetanib—thyroid cancer	0.00505	0.00505	CcSEcCtD
Terazosin—Dysgeusia—Sorafenib—thyroid cancer	0.005	0.005	CcSEcCtD
Terazosin—Vasodilation—Epirubicin—thyroid cancer	0.00492	0.00492	CcSEcCtD
Terazosin—Vasodilation procedure—Epirubicin—thyroid cancer	0.00492	0.00492	CcSEcCtD
Terazosin—Abdominal pain—Vandetanib—thyroid cancer	0.00489	0.00489	CcSEcCtD
Terazosin—Body temperature increased—Vandetanib—thyroid cancer	0.00489	0.00489	CcSEcCtD
Terazosin—Arthropathy—Epirubicin—thyroid cancer	0.00475	0.00475	CcSEcCtD
Terazosin—Cough increased—Epirubicin—thyroid cancer	0.00472	0.00472	CcSEcCtD
Terazosin—Angioedema—Sorafenib—thyroid cancer	0.00467	0.00467	CcSEcCtD
Terazosin—Syncope—Sorafenib—thyroid cancer	0.00458	0.00458	CcSEcCtD
Terazosin—Vasodilation—Doxorubicin—thyroid cancer	0.00455	0.00455	CcSEcCtD
Terazosin—Vasodilation procedure—Doxorubicin—thyroid cancer	0.00455	0.00455	CcSEcCtD
Terazosin—Loss of consciousness—Sorafenib—thyroid cancer	0.00449	0.00449	CcSEcCtD
Terazosin—Cough—Sorafenib—thyroid cancer	0.00446	0.00446	CcSEcCtD
Terazosin—Asthenia—Vandetanib—thyroid cancer	0.00443	0.00443	CcSEcCtD
Terazosin—Coordination abnormal—Epirubicin—thyroid cancer	0.0044	0.0044	CcSEcCtD
Terazosin—Arthropathy—Doxorubicin—thyroid cancer	0.00439	0.00439	CcSEcCtD
Terazosin—Pruritus—Vandetanib—thyroid cancer	0.00437	0.00437	CcSEcCtD
Terazosin—Neck pain—Epirubicin—thyroid cancer	0.00437	0.00437	CcSEcCtD
Terazosin—Musculoskeletal pain—Epirubicin—thyroid cancer	0.00437	0.00437	CcSEcCtD
Terazosin—Cough increased—Doxorubicin—thyroid cancer	0.00437	0.00437	CcSEcCtD
Terazosin—Myalgia—Sorafenib—thyroid cancer	0.00435	0.00435	CcSEcCtD
Terazosin—Arthralgia—Sorafenib—thyroid cancer	0.00435	0.00435	CcSEcCtD
Terazosin—Abnormal dreams—Epirubicin—thyroid cancer	0.00427	0.00427	CcSEcCtD
Terazosin—Dry mouth—Sorafenib—thyroid cancer	0.00425	0.00425	CcSEcCtD
Terazosin—Diarrhoea—Vandetanib—thyroid cancer	0.00423	0.00423	CcSEcCtD
Terazosin—Anaphylactic shock—Sorafenib—thyroid cancer	0.00417	0.00417	CcSEcCtD
Terazosin—Shock—Sorafenib—thyroid cancer	0.0041	0.0041	CcSEcCtD
Terazosin—Dizziness—Vandetanib—thyroid cancer	0.00409	0.00409	CcSEcCtD
Terazosin—Thrombocytopenia—Sorafenib—thyroid cancer	0.00408	0.00408	CcSEcCtD
Terazosin—Coordination abnormal—Doxorubicin—thyroid cancer	0.00407	0.00407	CcSEcCtD
Terazosin—Musculoskeletal pain—Doxorubicin—thyroid cancer	0.00404	0.00404	CcSEcCtD
Terazosin—Neck pain—Doxorubicin—thyroid cancer	0.00404	0.00404	CcSEcCtD
Terazosin—Anorexia—Sorafenib—thyroid cancer	0.00397	0.00397	CcSEcCtD
Terazosin—Abnormal dreams—Doxorubicin—thyroid cancer	0.00395	0.00395	CcSEcCtD
Terazosin—Vomiting—Vandetanib—thyroid cancer	0.00393	0.00393	CcSEcCtD
Terazosin—Rash—Vandetanib—thyroid cancer	0.0039	0.0039	CcSEcCtD
Terazosin—Dermatitis—Vandetanib—thyroid cancer	0.00389	0.00389	CcSEcCtD
Terazosin—Headache—Vandetanib—thyroid cancer	0.00387	0.00387	CcSEcCtD
Terazosin—Musculoskeletal discomfort—Sorafenib—thyroid cancer	0.0038	0.0038	CcSEcCtD
Terazosin—Abnormal vision—Epirubicin—thyroid cancer	0.00377	0.00377	CcSEcCtD
Terazosin—Dyspnoea—Sorafenib—thyroid cancer	0.00372	0.00372	CcSEcCtD
Terazosin—Nausea—Vandetanib—thyroid cancer	0.00367	0.00367	CcSEcCtD
Terazosin—Dyspepsia—Sorafenib—thyroid cancer	0.00367	0.00367	CcSEcCtD
Terazosin—Decreased appetite—Sorafenib—thyroid cancer	0.00362	0.00362	CcSEcCtD
Terazosin—Fatigue—Sorafenib—thyroid cancer	0.00359	0.00359	CcSEcCtD
Terazosin—Photosensitivity—Epirubicin—thyroid cancer	0.00357	0.00357	CcSEcCtD
Terazosin—Constipation—Sorafenib—thyroid cancer	0.00357	0.00357	CcSEcCtD
Terazosin—Pain—Sorafenib—thyroid cancer	0.00357	0.00357	CcSEcCtD
Terazosin—Abnormal vision—Doxorubicin—thyroid cancer	0.00349	0.00349	CcSEcCtD
Terazosin—Gastrointestinal pain—Sorafenib—thyroid cancer	0.00341	0.00341	CcSEcCtD
Terazosin—Photosensitivity—Doxorubicin—thyroid cancer	0.0033	0.0033	CcSEcCtD
Terazosin—Abdominal pain—Sorafenib—thyroid cancer	0.0033	0.0033	CcSEcCtD
Terazosin—Body temperature increased—Sorafenib—thyroid cancer	0.0033	0.0033	CcSEcCtD
Terazosin—Anaphylactoid reaction—Epirubicin—thyroid cancer	0.00324	0.00324	CcSEcCtD
Terazosin—Cardiac failure—Epirubicin—thyroid cancer	0.00321	0.00321	CcSEcCtD
Terazosin—Cerebrovascular accident—Epirubicin—thyroid cancer	0.0032	0.0032	CcSEcCtD
Terazosin—Pain in extremity—Epirubicin—thyroid cancer	0.00314	0.00314	CcSEcCtD
Terazosin—Osteoarthritis—Epirubicin—thyroid cancer	0.00314	0.00314	CcSEcCtD
Terazosin—Migraine—Epirubicin—thyroid cancer	0.00309	0.00309	CcSEcCtD
Terazosin—Hypersensitivity—Sorafenib—thyroid cancer	0.00307	0.00307	CcSEcCtD
Terazosin—Face oedema—Epirubicin—thyroid cancer	0.00303	0.00303	CcSEcCtD
Terazosin—Anaphylactoid reaction—Doxorubicin—thyroid cancer	0.003	0.003	CcSEcCtD
Terazosin—Asthenia—Sorafenib—thyroid cancer	0.00299	0.00299	CcSEcCtD
Terazosin—Cardiac failure—Doxorubicin—thyroid cancer	0.00297	0.00297	CcSEcCtD
Terazosin—Cerebrovascular accident—Doxorubicin—thyroid cancer	0.00296	0.00296	CcSEcCtD
Terazosin—Pruritus—Sorafenib—thyroid cancer	0.00295	0.00295	CcSEcCtD
Terazosin—Pain in extremity—Doxorubicin—thyroid cancer	0.0029	0.0029	CcSEcCtD
Terazosin—Osteoarthritis—Doxorubicin—thyroid cancer	0.0029	0.0029	CcSEcCtD
Terazosin—Orthostatic hypotension—Epirubicin—thyroid cancer	0.00286	0.00286	CcSEcCtD
Terazosin—Migraine—Doxorubicin—thyroid cancer	0.00286	0.00286	CcSEcCtD
Terazosin—Hypokalaemia—Epirubicin—thyroid cancer	0.00285	0.00285	CcSEcCtD
Terazosin—Diarrhoea—Sorafenib—thyroid cancer	0.00285	0.00285	CcSEcCtD
Terazosin—Nasopharyngitis—Epirubicin—thyroid cancer	0.0028	0.0028	CcSEcCtD
Terazosin—Face oedema—Doxorubicin—thyroid cancer	0.0028	0.0028	CcSEcCtD
Terazosin—Gastritis—Epirubicin—thyroid cancer	0.00277	0.00277	CcSEcCtD
Terazosin—Dizziness—Sorafenib—thyroid cancer	0.00276	0.00276	CcSEcCtD
Terazosin—Influenza—Epirubicin—thyroid cancer	0.00271	0.00271	CcSEcCtD
Terazosin—Asthma—Epirubicin—thyroid cancer	0.00271	0.00271	CcSEcCtD
Terazosin—Vomiting—Sorafenib—thyroid cancer	0.00265	0.00265	CcSEcCtD
Terazosin—Orthostatic hypotension—Doxorubicin—thyroid cancer	0.00265	0.00265	CcSEcCtD
Terazosin—Hypokalaemia—Doxorubicin—thyroid cancer	0.00264	0.00264	CcSEcCtD
Terazosin—Angina pectoris—Epirubicin—thyroid cancer	0.00264	0.00264	CcSEcCtD
Terazosin—Rash—Sorafenib—thyroid cancer	0.00263	0.00263	CcSEcCtD
Terazosin—Dermatitis—Sorafenib—thyroid cancer	0.00263	0.00263	CcSEcCtD
Terazosin—Headache—Sorafenib—thyroid cancer	0.00261	0.00261	CcSEcCtD
Terazosin—Bronchitis—Epirubicin—thyroid cancer	0.00261	0.00261	CcSEcCtD
Terazosin—Nasopharyngitis—Doxorubicin—thyroid cancer	0.00259	0.00259	CcSEcCtD
Terazosin—Gastritis—Doxorubicin—thyroid cancer	0.00257	0.00257	CcSEcCtD
Terazosin—Dysuria—Epirubicin—thyroid cancer	0.00253	0.00253	CcSEcCtD
Terazosin—Asthma—Doxorubicin—thyroid cancer	0.00251	0.00251	CcSEcCtD
Terazosin—Influenza—Doxorubicin—thyroid cancer	0.00251	0.00251	CcSEcCtD
Terazosin—Pollakiuria—Epirubicin—thyroid cancer	0.0025	0.0025	CcSEcCtD
Terazosin—Nausea—Sorafenib—thyroid cancer	0.00248	0.00248	CcSEcCtD
Terazosin—Photosensitivity reaction—Epirubicin—thyroid cancer	0.00247	0.00247	CcSEcCtD
Terazosin—Weight increased—Epirubicin—thyroid cancer	0.00247	0.00247	CcSEcCtD
Terazosin—Angina pectoris—Doxorubicin—thyroid cancer	0.00244	0.00244	CcSEcCtD
Terazosin—Bronchitis—Doxorubicin—thyroid cancer	0.00241	0.00241	CcSEcCtD
Terazosin—Jaundice—Epirubicin—thyroid cancer	0.00236	0.00236	CcSEcCtD
Terazosin—Conjunctivitis—Epirubicin—thyroid cancer	0.00235	0.00235	CcSEcCtD
Terazosin—Urinary tract infection—Epirubicin—thyroid cancer	0.00235	0.00235	CcSEcCtD
Terazosin—Dysuria—Doxorubicin—thyroid cancer	0.00234	0.00234	CcSEcCtD
Terazosin—Sweating—Epirubicin—thyroid cancer	0.00232	0.00232	CcSEcCtD
Terazosin—Pollakiuria—Doxorubicin—thyroid cancer	0.00232	0.00232	CcSEcCtD
Terazosin—Photosensitivity reaction—Doxorubicin—thyroid cancer	0.00229	0.00229	CcSEcCtD
Terazosin—Weight increased—Doxorubicin—thyroid cancer	0.00228	0.00228	CcSEcCtD
Terazosin—Epistaxis—Epirubicin—thyroid cancer	0.00228	0.00228	CcSEcCtD
Terazosin—Sinusitis—Epirubicin—thyroid cancer	0.00227	0.00227	CcSEcCtD
Terazosin—Jaundice—Doxorubicin—thyroid cancer	0.00218	0.00218	CcSEcCtD
Terazosin—Rhinitis—Epirubicin—thyroid cancer	0.00217	0.00217	CcSEcCtD
Terazosin—Urinary tract infection—Doxorubicin—thyroid cancer	0.00217	0.00217	CcSEcCtD
Terazosin—Conjunctivitis—Doxorubicin—thyroid cancer	0.00217	0.00217	CcSEcCtD
Terazosin—Pharyngitis—Epirubicin—thyroid cancer	0.00215	0.00215	CcSEcCtD
Terazosin—Sweating—Doxorubicin—thyroid cancer	0.00214	0.00214	CcSEcCtD
Terazosin—Oedema peripheral—Epirubicin—thyroid cancer	0.00214	0.00214	CcSEcCtD
Terazosin—Epistaxis—Doxorubicin—thyroid cancer	0.00211	0.00211	CcSEcCtD
Terazosin—Sinusitis—Doxorubicin—thyroid cancer	0.0021	0.0021	CcSEcCtD
Terazosin—Visual impairment—Epirubicin—thyroid cancer	0.00209	0.00209	CcSEcCtD
Terazosin—Eye disorder—Epirubicin—thyroid cancer	0.00203	0.00203	CcSEcCtD
Terazosin—Tinnitus—Epirubicin—thyroid cancer	0.00202	0.00202	CcSEcCtD
Terazosin—Rhinitis—Doxorubicin—thyroid cancer	0.00201	0.00201	CcSEcCtD
Terazosin—Pharyngitis—Doxorubicin—thyroid cancer	0.00199	0.00199	CcSEcCtD
Terazosin—Oedema peripheral—Doxorubicin—thyroid cancer	0.00198	0.00198	CcSEcCtD
Terazosin—Arrhythmia—Epirubicin—thyroid cancer	0.00194	0.00194	CcSEcCtD
Terazosin—Visual impairment—Doxorubicin—thyroid cancer	0.00193	0.00193	CcSEcCtD
Terazosin—Malnutrition—Epirubicin—thyroid cancer	0.00189	0.00189	CcSEcCtD
Terazosin—Eye disorder—Doxorubicin—thyroid cancer	0.00188	0.00188	CcSEcCtD
Terazosin—Tinnitus—Doxorubicin—thyroid cancer	0.00187	0.00187	CcSEcCtD
Terazosin—Flatulence—Epirubicin—thyroid cancer	0.00186	0.00186	CcSEcCtD
Terazosin—Tension—Epirubicin—thyroid cancer	0.00185	0.00185	CcSEcCtD
Terazosin—Dysgeusia—Epirubicin—thyroid cancer	0.00185	0.00185	CcSEcCtD
Terazosin—Nervousness—Epirubicin—thyroid cancer	0.00183	0.00183	CcSEcCtD
Terazosin—Back pain—Epirubicin—thyroid cancer	0.00183	0.00183	CcSEcCtD
Terazosin—Arrhythmia—Doxorubicin—thyroid cancer	0.00179	0.00179	CcSEcCtD
Terazosin—Vision blurred—Epirubicin—thyroid cancer	0.00178	0.00178	CcSEcCtD
Terazosin—Ill-defined disorder—Epirubicin—thyroid cancer	0.00175	0.00175	CcSEcCtD
Terazosin—Malnutrition—Doxorubicin—thyroid cancer	0.00175	0.00175	CcSEcCtD
Terazosin—Flatulence—Doxorubicin—thyroid cancer	0.00172	0.00172	CcSEcCtD
Terazosin—Tension—Doxorubicin—thyroid cancer	0.00171	0.00171	CcSEcCtD
Terazosin—Dysgeusia—Doxorubicin—thyroid cancer	0.00171	0.00171	CcSEcCtD
Terazosin—Malaise—Epirubicin—thyroid cancer	0.0017	0.0017	CcSEcCtD
Terazosin—Nervousness—Doxorubicin—thyroid cancer	0.0017	0.0017	CcSEcCtD
Terazosin—Vertigo—Epirubicin—thyroid cancer	0.0017	0.0017	CcSEcCtD
Terazosin—Syncope—Epirubicin—thyroid cancer	0.00169	0.00169	CcSEcCtD
Terazosin—Back pain—Doxorubicin—thyroid cancer	0.00169	0.00169	CcSEcCtD
Terazosin—Palpitations—Epirubicin—thyroid cancer	0.00167	0.00167	CcSEcCtD
Terazosin—Loss of consciousness—Epirubicin—thyroid cancer	0.00166	0.00166	CcSEcCtD
Terazosin—Cough—Epirubicin—thyroid cancer	0.00165	0.00165	CcSEcCtD
Terazosin—Vision blurred—Doxorubicin—thyroid cancer	0.00165	0.00165	CcSEcCtD
Terazosin—Convulsion—Epirubicin—thyroid cancer	0.00164	0.00164	CcSEcCtD
Terazosin—Ill-defined disorder—Doxorubicin—thyroid cancer	0.00162	0.00162	CcSEcCtD
Terazosin—Chest pain—Epirubicin—thyroid cancer	0.00161	0.00161	CcSEcCtD
Terazosin—Myalgia—Epirubicin—thyroid cancer	0.00161	0.00161	CcSEcCtD
Terazosin—Arthralgia—Epirubicin—thyroid cancer	0.00161	0.00161	CcSEcCtD
Terazosin—Anxiety—Epirubicin—thyroid cancer	0.0016	0.0016	CcSEcCtD
Terazosin—Discomfort—Epirubicin—thyroid cancer	0.00159	0.00159	CcSEcCtD
Terazosin—Malaise—Doxorubicin—thyroid cancer	0.00158	0.00158	CcSEcCtD
Terazosin—Dry mouth—Epirubicin—thyroid cancer	0.00157	0.00157	CcSEcCtD
Terazosin—Vertigo—Doxorubicin—thyroid cancer	0.00157	0.00157	CcSEcCtD
Terazosin—Syncope—Doxorubicin—thyroid cancer	0.00157	0.00157	CcSEcCtD
Terazosin—Confusional state—Epirubicin—thyroid cancer	0.00155	0.00155	CcSEcCtD
Terazosin—Palpitations—Doxorubicin—thyroid cancer	0.00154	0.00154	CcSEcCtD
Terazosin—Oedema—Epirubicin—thyroid cancer	0.00154	0.00154	CcSEcCtD
Terazosin—Anaphylactic shock—Epirubicin—thyroid cancer	0.00154	0.00154	CcSEcCtD
Terazosin—Loss of consciousness—Doxorubicin—thyroid cancer	0.00154	0.00154	CcSEcCtD
Terazosin—Cough—Doxorubicin—thyroid cancer	0.00152	0.00152	CcSEcCtD
Terazosin—Shock—Epirubicin—thyroid cancer	0.00152	0.00152	CcSEcCtD
Terazosin—Convulsion—Doxorubicin—thyroid cancer	0.00151	0.00151	CcSEcCtD
Terazosin—Thrombocytopenia—Epirubicin—thyroid cancer	0.00151	0.00151	CcSEcCtD
Terazosin—Tachycardia—Epirubicin—thyroid cancer	0.0015	0.0015	CcSEcCtD
Terazosin—Hyperhidrosis—Epirubicin—thyroid cancer	0.00149	0.00149	CcSEcCtD
Terazosin—Chest pain—Doxorubicin—thyroid cancer	0.00149	0.00149	CcSEcCtD
Terazosin—Myalgia—Doxorubicin—thyroid cancer	0.00149	0.00149	CcSEcCtD
Terazosin—Arthralgia—Doxorubicin—thyroid cancer	0.00149	0.00149	CcSEcCtD
Terazosin—Anxiety—Doxorubicin—thyroid cancer	0.00148	0.00148	CcSEcCtD
Terazosin—Discomfort—Doxorubicin—thyroid cancer	0.00147	0.00147	CcSEcCtD
Terazosin—Anorexia—Epirubicin—thyroid cancer	0.00147	0.00147	CcSEcCtD
Terazosin—Dry mouth—Doxorubicin—thyroid cancer	0.00145	0.00145	CcSEcCtD
Terazosin—Hypotension—Epirubicin—thyroid cancer	0.00144	0.00144	CcSEcCtD
Terazosin—Confusional state—Doxorubicin—thyroid cancer	0.00144	0.00144	CcSEcCtD
Terazosin—Oedema—Doxorubicin—thyroid cancer	0.00143	0.00143	CcSEcCtD
Terazosin—Anaphylactic shock—Doxorubicin—thyroid cancer	0.00143	0.00143	CcSEcCtD
Terazosin—Musculoskeletal discomfort—Epirubicin—thyroid cancer	0.0014	0.0014	CcSEcCtD
Terazosin—Shock—Doxorubicin—thyroid cancer	0.0014	0.0014	CcSEcCtD
Terazosin—Thrombocytopenia—Doxorubicin—thyroid cancer	0.0014	0.0014	CcSEcCtD
Terazosin—Insomnia—Epirubicin—thyroid cancer	0.00139	0.00139	CcSEcCtD
Terazosin—Tachycardia—Doxorubicin—thyroid cancer	0.00139	0.00139	CcSEcCtD
Terazosin—Paraesthesia—Epirubicin—thyroid cancer	0.00138	0.00138	CcSEcCtD
Terazosin—Hyperhidrosis—Doxorubicin—thyroid cancer	0.00138	0.00138	CcSEcCtD
Terazosin—Dyspnoea—Epirubicin—thyroid cancer	0.00137	0.00137	CcSEcCtD
Terazosin—Somnolence—Epirubicin—thyroid cancer	0.00137	0.00137	CcSEcCtD
Terazosin—Anorexia—Doxorubicin—thyroid cancer	0.00136	0.00136	CcSEcCtD
Terazosin—Dyspepsia—Epirubicin—thyroid cancer	0.00136	0.00136	CcSEcCtD
Terazosin—Decreased appetite—Epirubicin—thyroid cancer	0.00134	0.00134	CcSEcCtD
Terazosin—Hypotension—Doxorubicin—thyroid cancer	0.00133	0.00133	CcSEcCtD
Terazosin—Fatigue—Epirubicin—thyroid cancer	0.00133	0.00133	CcSEcCtD
Terazosin—Constipation—Epirubicin—thyroid cancer	0.00132	0.00132	CcSEcCtD
Terazosin—Pain—Epirubicin—thyroid cancer	0.00132	0.00132	CcSEcCtD
Terazosin—Musculoskeletal discomfort—Doxorubicin—thyroid cancer	0.0013	0.0013	CcSEcCtD
Terazosin—Insomnia—Doxorubicin—thyroid cancer	0.00129	0.00129	CcSEcCtD
Terazosin—Paraesthesia—Doxorubicin—thyroid cancer	0.00128	0.00128	CcSEcCtD
Terazosin—Dyspnoea—Doxorubicin—thyroid cancer	0.00127	0.00127	CcSEcCtD
Terazosin—Feeling abnormal—Epirubicin—thyroid cancer	0.00127	0.00127	CcSEcCtD
Terazosin—Somnolence—Doxorubicin—thyroid cancer	0.00127	0.00127	CcSEcCtD
Terazosin—Gastrointestinal pain—Epirubicin—thyroid cancer	0.00126	0.00126	CcSEcCtD
Terazosin—Dyspepsia—Doxorubicin—thyroid cancer	0.00126	0.00126	CcSEcCtD
Terazosin—Decreased appetite—Doxorubicin—thyroid cancer	0.00124	0.00124	CcSEcCtD
Terazosin—Fatigue—Doxorubicin—thyroid cancer	0.00123	0.00123	CcSEcCtD
Terazosin—Constipation—Doxorubicin—thyroid cancer	0.00122	0.00122	CcSEcCtD
Terazosin—Pain—Doxorubicin—thyroid cancer	0.00122	0.00122	CcSEcCtD
Terazosin—Abdominal pain—Epirubicin—thyroid cancer	0.00122	0.00122	CcSEcCtD
Terazosin—Body temperature increased—Epirubicin—thyroid cancer	0.00122	0.00122	CcSEcCtD
Terazosin—Feeling abnormal—Doxorubicin—thyroid cancer	0.00117	0.00117	CcSEcCtD
Terazosin—Gastrointestinal pain—Doxorubicin—thyroid cancer	0.00117	0.00117	CcSEcCtD
Terazosin—Hypersensitivity—Epirubicin—thyroid cancer	0.00114	0.00114	CcSEcCtD
Terazosin—Body temperature increased—Doxorubicin—thyroid cancer	0.00113	0.00113	CcSEcCtD
Terazosin—Abdominal pain—Doxorubicin—thyroid cancer	0.00113	0.00113	CcSEcCtD
Terazosin—Asthenia—Epirubicin—thyroid cancer	0.00111	0.00111	CcSEcCtD
Terazosin—Pruritus—Epirubicin—thyroid cancer	0.00109	0.00109	CcSEcCtD
Terazosin—Diarrhoea—Epirubicin—thyroid cancer	0.00105	0.00105	CcSEcCtD
Terazosin—Hypersensitivity—Doxorubicin—thyroid cancer	0.00105	0.00105	CcSEcCtD
Terazosin—Asthenia—Doxorubicin—thyroid cancer	0.00102	0.00102	CcSEcCtD
Terazosin—Dizziness—Epirubicin—thyroid cancer	0.00102	0.00102	CcSEcCtD
Terazosin—Pruritus—Doxorubicin—thyroid cancer	0.00101	0.00101	CcSEcCtD
Terazosin—Vomiting—Epirubicin—thyroid cancer	0.00098	0.00098	CcSEcCtD
Terazosin—Diarrhoea—Doxorubicin—thyroid cancer	0.000976	0.000976	CcSEcCtD
Terazosin—Rash—Epirubicin—thyroid cancer	0.000972	0.000972	CcSEcCtD
Terazosin—Dermatitis—Epirubicin—thyroid cancer	0.000971	0.000971	CcSEcCtD
Terazosin—Headache—Epirubicin—thyroid cancer	0.000965	0.000965	CcSEcCtD
Terazosin—Dizziness—Doxorubicin—thyroid cancer	0.000943	0.000943	CcSEcCtD
Terazosin—Nausea—Epirubicin—thyroid cancer	0.000915	0.000915	CcSEcCtD
Terazosin—Vomiting—Doxorubicin—thyroid cancer	0.000907	0.000907	CcSEcCtD
Terazosin—Rash—Doxorubicin—thyroid cancer	0.000899	0.000899	CcSEcCtD
Terazosin—Dermatitis—Doxorubicin—thyroid cancer	0.000898	0.000898	CcSEcCtD
Terazosin—Headache—Doxorubicin—thyroid cancer	0.000893	0.000893	CcSEcCtD
Terazosin—Nausea—Doxorubicin—thyroid cancer	0.000847	0.000847	CcSEcCtD
